Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Channel Therapeutics Corporation Common Stock (NY:CHRO)

1.420 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 90
Open 1.420
Bid (Size) 1.340 (8)
Ask (Size) 1.400 (2)
Prev. Close 1.420
Today's Range 1.420 - 1.420
52wk Range 0.4500 - 3.800
Shares Outstanding 23,083,169,588
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
+96.3%
+96.3%
1 Month
-35.5%
-35.5%
3 Month
+124.3%
+124.3%
6 Month
+100.0%
+100.0%
1 Year
-40.6%
-40.6%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
From Virtual Investor Conferences
Via GlobeNewswire
CHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
CHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Ride-Hailing Startup Ryde Makes Public Debut
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market

Frequently Asked Questions

Is Channel Therapeutics Corporation Common Stock publicly traded?
Yes, Channel Therapeutics Corporation Common Stock is publicly traded.
What exchange does Channel Therapeutics Corporation Common Stock trade on?
Channel Therapeutics Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Channel Therapeutics Corporation Common Stock?
The ticker symbol for Channel Therapeutics Corporation Common Stock is CHRO on the New York Stock Exchange
What is the current price of Channel Therapeutics Corporation Common Stock?
The current price of Channel Therapeutics Corporation Common Stock is 1.420
When was Channel Therapeutics Corporation Common Stock last traded?
The last trade of Channel Therapeutics Corporation Common Stock was at 03/31/25 08:00 PM ET
What is the market capitalization of Channel Therapeutics Corporation Common Stock?
The market capitalization of Channel Therapeutics Corporation Common Stock is 32.78B
How many shares of Channel Therapeutics Corporation Common Stock are outstanding?
Channel Therapeutics Corporation Common Stock has 33B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.